Jan 23, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
Jan 22, 2020 - Strapped with debt and battling legal controversies right and left, Teva’s best days could very well be behind it.
Jan 22, 2020 - Teva is set to hold the $10 support line.Company's restructuring and debt reduction on schedule.Future growth in place with two products leading it.
Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
Jan 21, 2020 - Jazz (JAZZ) receives approval for Sunosi as a treatment for excessive daytime sleepiness in narcolepsy or obstructive sleep apnea patients in Europe.
Jan 14, 2020 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with this event.
Jan 13, 2020 - Teva Pharmaceutical Industries Limited (NYSE:TEVA) 38th Annual JP Morgan Healthcare Conference January 13, 2020 01:30 PM ET Company Participants Kåre Schultz - President and Chief Executive Officer Co
Jan 06, 2020 - The attorney representing two former sales reps at Teva Pharmaceutical Industries (TEVA -0.8%) announces that the company has agreed to pay $54M to settle allegations that it used sham paid speaker pr
Dec 30, 2019 - These four stocks will hopefully be bringing home the bacon in the new year.
Dec 26, 2019 - Ubrelvy is proven to ease migraine symptoms in two hours.